Verrica Pharmaceuticals Inc. - FORM S-1 - EX-23.1 - May 22, 2018

Attached files

file filename
EX-10.16 - EX-10.16 - Verrica Pharmaceuticals Inc.d361077dex1016.htm
EX-10.17 - EX-10.17 - Verrica Pharmaceuticals Inc.d361077dex1017.htm
EX-10.15 - EX-10.15 - Verrica Pharmaceuticals Inc.d361077dex1015.htm
EX-10.14 - EX-10.14 - Verrica Pharmaceuticals Inc.d361077dex1014.htm
EX-10.13 - EX-10.13 - Verrica Pharmaceuticals Inc.d361077dex1013.htm
EX-10.12 - EX-10.12 - Verrica Pharmaceuticals Inc.d361077dex1012.htm
EX-10.11 - EX-10.11 - Verrica Pharmaceuticals Inc.d361077dex1011.htm
EX-10.10 - EX-10.10 - Verrica Pharmaceuticals Inc.d361077dex1010.htm
EX-10.9 - EX-10.9 - Verrica Pharmaceuticals Inc.d361077dex109.htm
EX-10.8 - EX-10.8 - Verrica Pharmaceuticals Inc.d361077dex108.htm
EX-10.7 - EX-10.7 - Verrica Pharmaceuticals Inc.d361077dex107.htm
EX-10.6 - EX-10.6 - Verrica Pharmaceuticals Inc.d361077dex106.htm
EX-10.3 - EX-10.3 - Verrica Pharmaceuticals Inc.d361077dex103.htm
EX-10.2 - EX-10.2 - Verrica Pharmaceuticals Inc.d361077dex102.htm
EX-10.1 - EX-10.1 - Verrica Pharmaceuticals Inc.d361077dex101.htm
EX-3.4 - EX-3.4 - Verrica Pharmaceuticals Inc.d361077dex34.htm
EX-3.3 - EX-3.3 - Verrica Pharmaceuticals Inc.d361077dex33.htm
EX-3.2 - EX-3.2 - Verrica Pharmaceuticals Inc.d361077dex32.htm
EX-3.1 - EX-3.1 - Verrica Pharmaceuticals Inc.d361077dex31.htm
S-1 - S-1 - Verrica Pharmaceuticals Inc.d361077ds1.htm

EXHIBIT 23.1

Consent of Independent Registered Public Accounting Firm

The Board of Directors

Verrica Pharmaceuticals Inc.:

We consent to the use of our report included herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Richmond, Virginia

May 18, 2018

Verrica Pharmaceuticals Inc. Reports